Hormonal
Metformin is effective for preventing type 2 diabetes in prediabetic women, with efficacy varying by menopausal stage and hormonal status.
If you are a woman with prediabetes, metformin is a proven tool to prevent type 2 diabetes, but its effectiveness depends heavily on your menopausal status. It works best for premenopausal women and those who have gone through natural menopause, rather than those who have had their ovaries removed. While lifestyle changes are the first step, metformin is particularly valuable for high-risk individuals (younger, higher BMI, history of gestational diabetes) where lifestyle changes alone may not be enough. Be prepared for potential gastrointestinal side effects, which often improve over time.
Metformin demonstrates varying levels of efficacy among women at different stages of menopause. It was found to be more effective in the pre-menopausal group... and in the postmenopausal group... Interestingly, when the postmenopausal group was further divided into women with natural menopause... and those who underwent bilateral oophorectomy... metformin was more effective in the former than the latter
Why this rating
Supported by multiple RCTs, meta-analyses, and prospective studies cited in the review.
Source
Metformin use in prediabetes: A review of evidence and a focus on metabolic features among peri‐menopausal women
Beth Shi Yu Lim et al. · Diabetes Obesity and Metabolism · 2025
DOI 10.1111/dom.16442
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →